Downtrend on the daily chart: below its 50- and 200-day averages · 50-day above the 200-day · SuperTrend down since Oct 14 · below the Ichimoku cloud · RSI 34 · MACD below its signal
| 8.10 | 52-week high | +77.24% |
| 5.79 | Previous month high | +26.70% |
| 5.45 | Previous week high | +19.26% |
| 5.01 | Previous month low | +9.63% |
| 4.95 | R3 (classic) | +8.35% |
| 4.88 | R2 (classic) | +6.68% |
| 4.80 | Previous day high | +5.01% |
| 4.72 | R1 (classic) | +3.34% |
| 4.65 | Pivot | +1.67% |
| 4.57 | Previous day low | +0.00% |
| 4.57 | Previous week low | +0.00% |
| 4.57 | Price now | |
| 4.49 | S1 (classic) | −1.67% |
| 4.42 | S2 (classic) | −3.34% |
| 4.26 | S3 (classic) | −6.68% |
| 3.40 | 52-week low | −25.60% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $63.6K | 0.00% | 57.80K | −11% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a INCR trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 22, 2022 | Fegel (Yael)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 22.70 per share. | 1.8K | $41.38K |
| Mar 21, 2022 | Fegel (Yael)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 22.85 per share. | 100K | $2.29M |
| Mar 20, 2022 | Fegel (Yael)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 22.50 per share. | 48.4K | $1.09M |
| Mar 15, 2022 | Fegel (Yael)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 21.10 per share. | 1.2K | $25.83K |
| Mar 14, 2022 | Fegel (Yael)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 21.08 per share. | 3K | $63.24K |
| Mar 14, 2022 | Fegel (Yael)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 21.24 per share. | 6K | $127.44K |
| Mar 14, 2022 | Fegel (Yael)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 21.06 per share. | 10K | $210.60K |
TimeframesDown on the hourly, daily and monthly, mixed on the weekly.
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
pulling back under the 21 EMA
under a falling 21 EMA, 21 under 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.4 | -10.1 | -9.5 | 12.1 | 42.5 | -8.3 | -12.5 | 19.8 | -8.5 | -13.3 | +0.4% | ||
| 2025 | 2.5 | -4.5 | -10.0 | 12.4 | -0.4 | -6.2 | -2.7 | 10.5 | 3.8 | -14.6 | -4.4 | -32.0 | −42.8% |
| 2024 | -8.5 | 65.3 | 39.0 | 7.7 | 1.0 | -31.9 | 9.0 | 3.7 | -11.5 | -14.4 | -22.7 | 19.5 | +23.3% |
| 2023 | 11.5 | -32.9 | -17.4 | 14.2 | -16.7 | -12.4 | -6.5 | 1.3 | -2.5 | -35.7 | 21.8 | 4.9 | −60.9% |
| 2022 | -4.9 | 4.9 | 9.9 | -18.5 | 11.4 | -10.2 | 1.4 | -11.9 | -13.0 | 7.1 | 2.9 | -33.5 | −49.1% |
| 2021 | 42.3 | -12.4 | -1.2 | 356.3 | 6.8 | -10.9 | -3.9 | -7.5 | 12.1 | -2.2 | 10.6 | -13.6 | +398.5% |
| 2020 | 0.0 | -11.3 | 9.1 | 0.8 | 14.0 | -20.3 | -9.1 | -20.0 | 12.5 | 1.1 | 64.8 | -13.3 | +4.8% |
| 2019 | -3.4 | 8.2 | -4.3 | -31.7 | -4.0 | -21.1 | 6.7 | -21.9 | 16.0 | -3.4 | -11.4 | −57.2% |
No analyst coverage for this instrument.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.